Facing months of intense scrutiny of meetings, companies have canceled program after program for no other reason than how those events might be perceived by the public and by shareholders...
A new law in Washington requiring pharmaceutical sales representatives to obtain a special license to sell pharmaceutical products in the District will not affect representatives attending medical meetings or conventions in D.C. The SafeRX law...
The American Medical Association's Council on Ethical and Judicial Affairs won't recommend a ban on commercial support, according to its much-anticipated follow-up report, “Financial Relationships With Industry in Continuing Medical Education,”...